Lineage Cell Therapeutics Inc (LCTX)

[terry hallinan]

I guess maybe now that they think they understand the genes implicated with cell regeneration, it may somehow be easier to interfere with those genes in cancerous cells

You are surely right on the money here, Bobby. No need to guess.

AST took the telomerase cancer vaccines [autologous and allogeneic {a vaccine generated from one's own tumor vs cultured tumor material}] with them when they spun off BTX. [BTX still holds a significant share.]

The telomerase promises ability to end aging. The cancer vaccines are designed to make immortal cancer cells mortal and destroy the bastids. Allogeneic vaccines have been a black hole for billions for decades but VAC2, the allogeneic vaccine just starting recruiting for a Phase I clinical trial in England lung cancers, has the very unusual qualification of being applicable to some 80% of all cancers and nearly all lung cancers.

Best, Terry